GlaxoSmithKline Hit With $89.7M Verdict For Inhaler IP
A federal jury in Delaware on Friday found that GlaxoSmithKline LLC and Glaxo Group Ltd. owe $89.7 million to U.K.-based Vectura Limited for infringing a single claim of a patent covering...To view the full article, register now.
Already a subscriber? Click here to view full article